Evidence map›Paper›PMID 42548656›Full record

ArticleFrontiers in immunology2026

Priming of human monocytes by β-glucan and obesity-associated factors: modifications to global DNA methylation, gene expression, phenotype and function.

Ben J Topham, Barry D Hock, George A R Wiggins, Louisa V Ashby, Nicholas J Magon, Elisabeth Phillips, Emma K C Symonds, Kirsty M Danielson, Margaret J Currie

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ben J TophamMackenzie Cancer Research Group, Department of Pathology & Molecular Medicine, University of Otago Christchurch, Christchurch, New Zealand.
Barry D HockHaematology Research Group, Department of Pathology & Molecular Medicine, University of Otago Christchurch, Christchurch, New Zealand.
George A R WigginsMackenzie Cancer Research Group, Department of Pathology & Molecular Medicine, University of Otago Christchurch, Christchurch, New Zealand.
Louisa V AshbyMātai Hāora - Centre for Redox Biology and Medicine, Department of Pathology & Molecular Medicine, University of Otago Christchurch, Christchurch, New Zealand.
Nicholas J MagonMātai Hāora - Centre for Redox Biology and Medicine, Department of Pathology & Molecular Medicine, University of Otago Christchurch, Christchurch, New Zealand.
Elisabeth PhillipsMackenzie Cancer Research Group, Department of Pathology & Molecular Medicine, University of Otago Christchurch, Christchurch, New Zealand.
Emma K C SymondsDepartment of Surgery and Critical Care, University of Otago Wellington, Wellington, New Zealand.
Kirsty M DanielsonDepartment of Surgery and Critical Care, University of Otago Wellington, Wellington, New Zealand.
Margaret J CurrieMackenzie Cancer Research Group, Department of Pathology & Molecular Medicine, University of Otago Christchurch, Christchurch, New Zealand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Monocytes play a critical role in regulating immune response to exogenous and endogenous challenge. Recent studies have shown exogenous stimuli can induce metabolic, epigenetic and phenotypic changes in monocytes that reprogramme or 'prime' them to react with an altered response to subsequent stimuli. Obesity is associated with immune dysfunction. However, the ability of endogenous compounds associated with obesity to prime human monocytes and thereby modulate subsequent response remains to be investigated. Methods and results: In this study, human monocytes from non-obese males were utilized. Monocytes exposed to primary exogenous stimuli (β-glucan), but not endogenous stimuli (oxLDL, leptin, 17β-estradiol), demonstrated an altered phenotype (increased CD11b, PD-L1 expression) in response to SK-MEL-28 melanoma cells. In contrast, monocytes primed with oxLDL, but not β-glucan, exhibited an increased rate of superoxide production in response to secondary stimulation with phorbol 12-myristate 13-acetate, and enhanced matrix metalloprotease 9 activity in response to secondary stimulation with lipopolysaccharide. Bulk RNAseq analysis of non-primed monocytes and monocytes primed with 17β-estradiol or oxLDL also showed sustained differential expression of genes related to immune function, metabolism and protein modification. Moreover, mass spectrometry analysis showed that monocytes primed with β-glucan or oxLDL exhibited sustained modifications to global DNA methylation. Conclusions: These results provide the first steps in understanding the functional consequences of monocyte reprogramming by obesity-related factors, and the potential pathways that govern them.

Indexed as

beta-GlucansDNA MethylationGene ExpressionMonocytesAdultB7-H1 AntigenCD11b AntigenCell Line, TumorCytidineEstradiolGene Expression ProfilingHumansLipoproteins, LDLMaleObesity5-hydroxymethylcytidine5-methylcytidineB7-H1 Antigenbeta-GlucansCD11b AntigenCytidineEstradiolITGAM protein, humanLipoproteins, LDLoxidized low density lipoproteinDNA methylationgene expressionimmune functioninnate primingobesity-related compounds

Identifiers

PMID42548656
PMCPMC13429425

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.